GGrantIndex
Sort

64,565 grants matching drug discovery

Advanced Human on a Chip Systems for Drug Discovery

$735,615
Michael L Shuler · Hesperos, Llc · R44 · FY2017 · TR

Antibody Therapy of Cancer

$735,484
Mitchell Ho · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Molecular Characterization of the SARS-CoV-2 Helicase and High-Throughput Screening to Identify Small Molecule SARS-CoV-2 Helicase Inhibitors as Anti-Viral Medicines

$735,446
Robert Brosh · National Institute On Aging · ZIA · FY2021 · AG

Integrated heart-liver-vascular systems for drug testing in human health and dise

$735,429
Gordana Vunjak-Novakovic · Columbia Univ New York Morningside · UH2 · FY2013 · EB

Advancing Pantothenate Kinase Activation Therapy

$735,373
Richard Edward Lee · St. Jude Children'S Research Hospital · R01 · FY2025 · NS

Advanced development of the Cancer Dependency Map portal (DepMap.org)

$735,340
Philip Montgomery · Broad Institute, Inc. · U24 · FY2024 · CA

Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders

$735,333
Martin H Teicher · Mclean Hospital · R01 · FY2022 · DA

Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders

$735,333
Martin H Teicher · Mclean Hospital · R01 · FY2023 · DA

Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders

$735,333
Martin H Teicher · Mclean Hospital · R01 · FY2021 · DA

Hijacking Plasmodium ubiquitin-proteasome system to defeat drug resistance

$735,318
Gang Lin · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · AI

Molecular Target Focused Discovery of Anticancer Drugs

$735,292
Arizona State University-Tempe Campus · R01 · FY2003 · CA

Optimization of methionyl-tRNA synthetase inhibitors for human African trypanosomiasis

$735,148
Erkang Fan · University Of Washington · R01 · FY2016 · AI

Small Molecule Inhibitors Against 3C-Like Protease of SARS-CoV-2

$735,037
Kyeong-Ok Chang · Kansas State University · R01 · FY2023 · AI

Small Molecule Inhibitors Against 3C-Like Protease of SARS-CoV-2

$735,037
Kyeong-Ok Chang · Kansas State University · R01 · FY2022 · AI

Small molecules for perturbing iron homeostasis in bacterial biofilms

$734,987
Mario Rivera · Louisiana State Univ A&M Col Baton Rouge · R01 · FY2024 · AI

Blood vessel assembly from multipotent hemangioma-derived stem cells

$734,971
Joyce E. Bischoff · Boston Children'S Hospital · R01 · FY2025 · HL

New drugs for non-tuberculous mycobacterial (NTM) lung disease in patients with cystic fibrosis

$734,965
Thomas Dick · Hackensack University Medical Center · U19 · FY2022 · AI

New drugs for non-tuberculous mycobacterial (NTM) lung disease in patients with cystic fibrosis

$734,964
Thomas Dick · Hackensack University Medical Center · U19 · FY2020 · AI

Structural Basis of Signal Instigation Through Metabotropic Glutamate Receptors

$734,961
Georgios Skiniotis · Stanford University · R01 · FY2018 · NS

Administrative Core

$734,932
David S Perlin · Hackensack University Medical Center · U19 · FY2023 · AI

Emerging virus-host cell protein interaction networks

$734,925
Douglas J. Lacount · Purdue University · R01 · FY2016 · AI

Emerging virus-host cell protein interaction networks

$734,925
Douglas J. Lacount · Purdue University · R01 · FY2017 · AI

An integrated in vitro model of perfused tumor and cardiac tissue

$734,877
Steven Carl George · University Of California-Irvine · UH2 · FY2012 · TR

Mid Southern Primary Care Networks Node

$734,852
Li-Tzy T Wu · Duke University · UG1 · FY2019 · DA

Epstein-Barr Virus LMP-1 Mediated Oncogenicity

$734,837
Elliott D Kieff · Brigham And Women'S Hospital · R01 · FY2006 · CA